The estimated Net Worth of Paul Thomas is at least $15.5 Milión dollars as of 1 September 2024. Mr. Thomas owns over 11,904 units of Abiomed stock worth over $12,212,453 and over the last 13 years he sold ABMD stock worth over $3,039,041. In addition, he makes $269,996 as Independent Director at Abiomed.
Paul has made over 11 trades of the Abiomed stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 11,904 units of ABMD stock worth $4,535,662 on 1 September 2024.
The largest trade he's ever made was exercising 11,904 units of Abiomed stock on 1 September 2024 worth over $4,535,662. On average, Paul trades about 1,688 units every 83 days since 2011. As of 1 September 2024 he still owns at least 32,052 units of Abiomed stock.
You can see the complete history of Mr. Thomas stock trades at the bottom of the page.
Paul G. Thomas serves as Independent Director of the Company. Mr. Thomas co-founded Prominex, Inc., a start-up company focused on the development of molecular diagnostic assays for point-of-care infectious disease testing. Mr. Thomas currently serves as Prominex’s Chief Executive Officer. Prior to his employment with Prominex, Mr. Thomas served as the founder, President, Chief Executive Officer and director of Roka Bioscience, Inc. from September 2009 until his retirement in January 2017. Previously, he served as President, Chief Executive Officer and Chairman of LifeCell from October 1998 until its acquisition by Kinetic Concepts. Prior to joining LifeCell, Mr. Thomas held various senior positions, including President of the Pharmaceuticals division, during a 15-year tenure with Ohmeda Inc. Mr. Thomas received his Bachelor of Science in Chemistry from St. Michael’s College and his Master of Business Administration from Columbia University, and completed his postgraduate studies in chemistry at the University of Georgia.
As the Independent Director of Abiomed, the total compensation of Paul Thomas at Abiomed is $269,996. There are 11 executives at Abiomed getting paid more, with Michael Minogue having the highest compensation of $16,612,800.
Paul Thomas is 64, he's been the Independent Director of Abiomed since 2011. There are 5 older and 12 younger executives at Abiomed. The oldest executive at Abiomed Inc. is Jeannine Rivet, 72, who is the Independent Director.
Paul's mailing address filed with the SEC is C/O AXOGEN, INC. 13631 PROGRESS BLVD, SUITE 400, ALACHUA, FL, 32615.
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose a David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: